Docencia

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years After Starting Antiretroviral Therapy (28-10-2016)

Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella

Antiretroviral Therapy for Prevention of HIV-1 Transmission (17-10-2016)

Dra. Concha Amador Prous. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. ESTUDIO PARTNER (30-09-2016)

Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal. Madrid

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapy (15-06-2016)

Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba

Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted proteaseinhibitor-based regimens for initial treatment of HIV infection: A systematic review andmeta-analysis of randomised trials (01-06-2016)

Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid

Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care (17-05-2016)

Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid

Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis (03-05-2016)

Dr. Felix Gutiérrez. Departamento de Medicina Clínica. Hospital General Universitario.Elche

A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Preven:on in Women (15-04-2016)

Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona

CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection (01-04-2016)

Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid

Ledipasvir Plus Sofosbuvir in Treatment- Naïve or-experienced Patients With Hepatitis C Genotype 5 Infection: An Open-Label, Phase 2 study Abergel A, et al. Lancet Infectious Diseases, 2016 (15-03-2016)

Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba

Switching from TDF to TAF in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: A randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. ENSAYO GS-US-292-0109 (01-03-2016)

Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estmated glomerular filtration rate: a prospective international cohort study (15-02-2016)

Dra. María Jesús Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection (01-02-2016)

Dr. Félix Gutierrez. Departamento de Medicina Clínica. Hospital General Universitario. Elche

Withdrawing inactive NRTIs in HIV-1 sujects with suppressed viraemia: a randomized trial (15-01-2016)

Dr. Josep Maria Llibre. Departamento de Medicina interna y Unidad de VIH. Hospital Germans Trias i Pujol. Badalona

Estudios ASTRAL 1, 2, 3 Y 4 (30-12-2015)

Dr. Juan Berenguer. Consultor de la Unidad de Enf. Infecciosas y VIH. Hospital Universitario Gregorio Marañón. Madrid

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in AfricaThe TEMPRANO ANRS 12136 Study GroupN Engl J Med. Volume 373(9):808-822. August 27, 2015 (15-12-2015)

Dr. Antonio Rivero Román. Jefe de sección de Enfermedades Infecciosas.Hospital Universitario Reina Sofía. Córdoba

High-Dose Vitamin D and Calcium Attenuates Bone Loss with Antiretroviral Therapy Initiation: A Prospective, Randomized Placebo-Controlled Trial for Bone Health in HIV-Infected Individuals (01-12-2015)

Dr. Federico Pulido. Unidad de Infección VIH Hospital 12 de Octubre. Madrid

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phaseof a pragmatic open-label randomised trial (15-11-2015)

Dra. María Jesus Téllez. Servicio de Medicina Interna/ Unidad VIH. Hospital Clínico San Carlos. Madrid

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3,non-inferiority trials (01-11-2015)

Dr. Félix Gutierrez. Departamento de Medicina Clínicia Hospital General Universitario. Elche

Página 6 de 71234567

Accesos directos